Wearable technology and the cardiovascular system: the future of patient assessment. The Lancet. Digital health Williams, G. J., Al-Baraikan, A., Rademakers, F. E., Ciravegna, F., van de Vosse, F. N., Lawrie, A., Rothman, A., Ashley, E. A., Wilkins, M. R., Lawford, P. V., Omholt, S. W., Wisløff, U., Hose, D. R., Chico, T. J., Gunn, J. P., Morris, P. D. 2023; 5 (7): e467-e476


The past decade has seen a dramatic rise in consumer technologies able to monitor a variety of cardiovascular parameters. Such devices initially recorded markers of exercise, but now include physiological and health-care focused measurements. The public are keen to adopt these devices in the belief that they are useful to identify and monitor cardiovascular disease. Clinicians are therefore often presented with health app data accompanied by a diverse range of concerns and queries. Herein, we assess whether these devices are accurate, their outputs validated, and whether they are suitable for professionals to make management decisions. We review underpinning methods and technologies and explore the evidence supporting the use of these devices as diagnostic and monitoring tools in hypertension, arrhythmia, heart failure, coronary artery disease, pulmonary hypertension, and valvular heart disease. Used correctly, they might improve health care and support research.

View details for DOI 10.1016/S2589-7500(23)00087-0

View details for PubMedID 37391266